baber/WOPTO huggingface dataset:
Patent NZ-502161-A (NZ)
Title: Method for automatically detecting linear seismic events in multiple element data for correcting geometry and static errors
Inventor: MARTIN FEDERICO
IPC: G01V1/28
Filed: 1998-07-08
Abstract: Methods are provided for automatic detection of linear seismic events and the detected events are used in correction of statics and geometry error. According to an example embodiment, a method is provided for automatically detecting substantially linear seismic events in multiple element data, and for correcting geometry and statics errors, wherein at least one element of the data comprises a shot and at least one other element of the data comprises a receiver, for a common element gather of traces, the method comprising: band pass filtering the traces; computing the complex trace envelope of traces of the gather; filtering out a DC component of the traces; sorting the gather by a first element line, a first element, a second element line, a second element, and an offset bin, wherein a sorted gather of traces is defined; wherein the computing and the sorting define a sorted gather of complex trace envelopes; transforming the sorted gather of complex trace envelopes into a set of velocity stack trace envelopes; wherein the traces are divergence corrected before the transforming and wherein the traces are positive bulk time shifted before the transforming; picking events from the velocity stack trace envelopes; determining statics error based on the picking; correcting static errors; determining geometry error based on the picking; and correcting the geometry error.
Patent NZ-505747-A (NZ)
Title: heater element, typically for electric water heater, with moulded plastic block, for eliminating prior art braised connection
Inventor: VICKERS PETER
IPC: F24H9/20
Filed: 2000-07-13
Abstract: A heater element (101) comprising: ·A heater element enclosed in a conductive sheath (104) formed such that two ends (102) there of terminate in close proximity; ·A conducting earthing yoke (107) connecting with the conductive heater element sheath, an insulative plastic mounting block (106) moulded over the ends of the sheathed heater element and encapsulating conductive earthing yoke, with terminal connections (111) of the ends of the heater element extending from an exterior face of mounting block; · Earthing means providing a connection with conductive earthing yoke from exterior face of mounting block and mounting means adapting to enable watertight securement of mounting block to a water heater container. Also described as a method of forming the heater element.
Patent NZ-510230-A (NZ)
Title: Predicting protein function by electronic comparison of functional site descriptors
Inventor: SKOLNICK JEFFREY
IPC: G16B20/00
Filed: 1999-05-27
Abstract: The present invention concerns methods and systems for predicting the biological function(s) of proteins. The invention is based on the development of functional site descriptors for discrete protein biological functions. Functional site descriptors are geometric representations of protein functional sites in three-dimensional space, and can also include additional parameters, for example, conformational information. Following their development, one or more functional site descriptors (for one or more different biological funtions) are used to probe protein structures to determine if such structures contain the functional sites described by the corresponding functional site descriptors. If so, the protein(s) containing the functional site(s) are predicted to have the corresponding biological function(s). In preferred embodiments, a library of functional site descriptors is used to probe inexact protein structures derived by computational methods from amino acid sequence information to predict the biological function(s) of such sequences and of the gene(s) encoding the same.
Patent NZ-512599-A (NZ)
Title: Formulation for cyclosporin administration featuring a hydrophilic solvent and a surfactant with a HLB of less than 5
Inventor: DOMB ABRAHAM J
IPC: A61K38/00
Filed: 1999-12-30
Abstract: Described is a formulation for the administration of a cyclosporin. This formulation features a hydrophilic solvent that is characterised by being a lower alkyl ester of hydroxyalkanoic acid; and a surfactant, preferably a combination of a surfactant with a high HLB (hydrophilic/lipophilic balance) of at least about 8 and a surfactant with a low HLB of less than about 5. Other ingredients are optional, such as a fatty acid ester such as tricaprin, a phospholipid, and an ethoxylated fat such as Cremophor or another similar substance. Optionally, the ethoxylated fat is substituted for the surfactant. The preferred particle size of the resultant formulation is less than about 100 nm, more preferably less than about 60 nm, and most preferably from about 5 nm to about 50 nm. The formulation of the present invention is characterised by having high bioavailability. The figure depicts a graph of cyclosporin blood concentration after oral administration of formulations described in order to demonstrate the effect of particle size on bioavailability.
Patent NZ-514745-A (NZ)
Title: Low profile anastomosis connector
Inventor: LOSHAKOVE AMIR
IPC: A61B17/08
Filed: 2000-03-20
Abstract: An anastomosis connector comprises a plurality of ring segments (106), together defining a radially expandable ring-like shape (106) having a lumen; at least one pivot bar (114) coupled to at least one of said ring segments (106); at least one spike (109) mounted on said pivot bar (114) and rotatable around said pivot bar (114), wherein radial deformation of said ring-like shape (106) does not substantially directly affect said spike (109) rotational position.
Patent NZ-519047-A (NZ)
Title: Membrane virus host range mutations and their uses as vaccine substrates
Inventor: BROWN DENNIS T
IPC: C07K14/18
Filed: 2000-03-14
Abstract: A genetically engineered membrane-enveloped virus wherein the virus encodes a transmembrane protein having a deletion. The deletion can either be deleterious, thus producing non-infectious virus particles, or nonsense thus producing virus particles with a correctly inserted transmembrane protein. The invention also includes a method of producing a viral vaccine for the vaccination of mammals. The vaccination can be carried out using mosquitoes as carriers of the vaccine.
Patent NZ-523353-A (NZ)
Title: Starch-based, meatless extruded shaped articles for easy administration to animals
Inventor: KALBE JOCHEN
IPC: A61K47/36
Filed: 2001-06-18
Abstract: Orally administered medicaments for animals, which are voluntarily ingested by the latter (e.g. dogs, cats and horses) are described. Also described is a method for producing the medicaments, which are starch-based extruded shaped articles comprising specific aromas, bodying agents and pharmaceutically active compounds and to their use to treat, in particular, as endoparasiticides.
Patent NZ-525262-A (NZ)
Title: Compositions comprising cyclohexamantane
Inventor: DAHL JEREMY E
IPC: C07C13/615
Filed: 2002-01-17
Abstract: Diamondoids are thermodynamically stable structures. Disclosed are compositions comprising at least 5% wt of cyclohexamantane (C26H30).
Patent NZ-525761-A (NZ)
Title: Improvements in marine anchors
Inventor: BRUCE PETER
IPC: B63B21/38
Filed: 2003-05-08
Abstract: Anchoring apparatus in the form of a marine anchor including a fluke member and a load application point on the marine anchor for attaching an anchor-line attachment- means, said anchor in operational configuration being an anchor for operation below the surface of a mooring bed characterized in that a straight line containing said load application point and the centroid of the fluke member surface viewable from said load application point when the anchor is in operation forms a forward-opening centroid angle b with a forward direction F, in which direction said fluke member surface has a minimum projected area, said angle b being in the range 68 to 85 for operation of the anchor in soft cohesice soil and being in the range 50 to 65 for operation in non-cohesive soil whereby a pulling force applied to the anchor by the anchor line at the anchor-line attachment-means load application point, when the anchor fluke centroid is buried at least twice the square root of said maximum projected area below the mooring bed surface causes the anchor to tend to move in the soil of the mooring bed with a substantial component of displacement in said forward direction F.
Patent NZ-528049-A (NZ)
Title: Laminate for packaging a product comprising a first film having an inside surface and an outside surface opposite the inside
Inventor: WOLF JOHN R
IPC: B32B27/08
Filed: 2002-03-13
Abstract: A packaging laminate useful as a lidstock comprises first and second films, and an image between the first and second films. The first film comprises a sealant layer forming the inside surface of the first film. The first film has a free shrink at 220 DEG F. in at least one direction of at least about 7%. The second film comprises an outside layer forming the outside surface of the second film. The outside layer comprises at least about 40% by weight of the outside layer of one or more relatively high-melt polymers each having a melting point at least about 25 DEG F. higher than the lowest melting point polymer of the sealant layer. The second film has a free shrink at 185 DEG F. of no more than about 10% in each of the machine and transverse directions. The outside surface of the first film is directly laminated to the inside surface of the second film. The first film has an oxygen transmission rate greater than the oxygen transmission rate of the second film. The laminate has an oxygen transmission rate of no more than about 100 cubic centimetres. The laminate 10 comprises sealant film laminated to barrier film to trap print image 16 between the sealant and barrier films. The sealant film may be monolayer, two-layer, or have three or more layers. Also, the barrier film may be monolayer, two-layer, or have three or more layers. The laminate 10 may be sealed to support member 18 (e. g., a tray) to form sealed package 20 enclosing food product 22.
Patent NZ-528937-A (NZ)
Title: The use of ecabet sodium for inflammatory disease in oral-cavity mucosa and the like
Inventor: KIMOTO YASUHIKO
IPC: A61P1/02
Filed: 2002-04-11
Abstract: The sulfodehydroabietic acid of formula (I) is used in the preparation of an agent for prophylaxis or treatment of inflammatory diseases in mucosa of oral cavity, pharynx or larynx, such as stomatitis, aphthous stomatitis and pharyngitis.
Patent NZ-530577-A (NZ)
Title: Treatment of nail infections with NO
Inventor: BENJAMIN NIGEL
IPC: A61P17/00
Filed: 2002-08-02
Abstract: Disclosed is the use of nitrogen oxide generating components in the manufacture of a medicament for the treatment or prophylaxis of a subunugal infection, wherein the components comprise a nitrate and an organic acid each separately disposed from the other prior to use.
Patent NZ-532018-A (NZ)
Title: Pyrrolidinone derivatives
Inventor: ZOU Dong
IPC: C07D405/04
Filed: 2002-09-26
Abstract: A pharmaceutical composition comprising a compound according to chemical formula as shown where: · Y is oxygen or sulfur; · V is aryl, heterocycle or cycloalkyl; · Z is halogen, alkyl, alkenyl, alkynyl, hydroxyl, amino, alkoxy, aryloxy, nitro or cyano; · R1 is hydrogen, halogen, alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, aryl or heterocycle; · R2 is hydrogen or hydroxyl; · R3 is -C(O)R3a, -C(O)N(R3a)(R3b), -S(O)R3a or -SR3a where R3a and R3b have independently the same meaning as R1' · R4 is hydroxyl, sulfanyl or amino; · t is 0, 1, 2, 3, 4 or 5. Above compositions may be used to treat conditions such as asthma, allergies, conjunctivitis, food allergy, eczema, inflammatory bowel disease, chronic obstructive pulmonary disease, otitis media, multiple sclerosis, HIV, dermatitis, Alzheimer's disease and cancer.
Patent NZ-532624-A (NZ)
Title: Alpha2delta ligands to treat tinnitus
Inventor: DOOLEY DAVID JAMES
IPC: A61K31/195
Filed: 2003-01-20
Abstract: Use of an alpha2delta ligand such as, for example, a compound of formula (II) and pharmaceutically acceptable salts thereof in the manufacture of a medicament for treating tinnitus is disclosed, wherein the alpha2delta ligand is not gabapentin or tiagabine, and wherein R1 is straight or branched unsubstituted alkyl of from 1 to 6 carbon atoms, unsubstituted phenyl, or unsubstituted cycloalkyl of from 3 to 6 carbon atoms; and R2 and R3 are each independently hydrogen or methyl.
Patent NZ-533329-A (NZ)
Title: Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
Inventor: CORDI ALEX
IPC: A61P25/18
Filed: 2002-12-20
Abstract: Disclosed are compounds and process of making compounds of formula (I) wherein: R1 represents an aryl or heteroaryl group; R2 represents a hydrogen atom, a halogen atom or an OH group; X represents an oxygen atom or a sulphur atom; Y represents an oxygen atom, a sulphur atom or an NR group wherein R represents a hydrogen atom or a linear or branched (C1-C6)alkyl group; A represents a CR4R5 group or an NR4 group wherein R4 and R5 are as defined in the specification; and R3 represents a hydrogen atom, a linear or branched (C1-C6) alkyl group or a (C3-C7)-cycloalkyl group. Compounds of the type described are useful in the treatment or prevention of mnemocognitive disorders associated with age, with anxiety or depressive syndromes, with progressive neurodegenerative diseases, with Alzheimer's disease, with Pick's disease, with Huntington's chorea, with schizophrenia, with sequelae of acute neurodegenerative diseases, with sequelae of ischemia and with sequelae of epilepsy.
Patent NZ-535047-A (NZ)
Title: Vascular impedance measurement apparatus
Inventor: MCVEIGH GARY EUGENE
IPC: A61B5/0285
Filed: 2003-04-22
Abstract: Apparatus and method for the measurement of vascular impedance of the ocular circulation in vivo are provided. A pressure pulse waveform is recorded from measurement of the intraocular pressure, and the velocity profile of blood flow in the retrobulbar circulation is recorded. These two readings are used to calculate the vascular impedance modulus.
Patent NZ-542687-A (NZ)
Title: Polymeric oligonucleotide prodrugs
Inventor: ZHAO HONG
IPC: C07H19/10
Filed: 2004-04-09
Abstract: Provided is an oligonucleotide prodrug of the formula: X1-(L2)n-(L1)o-R1 wherein: R1 is a substantially non-antigenic and water-soluble polymer residue with an average molecular weight of from about 2,000 to about 136,000 daltons; L1 a releasable linking moiety; L2 is a selected bifunctional spacing group comprising from about 2 to about 10 carbon atoms; X1 is a single or double stranded oligonucleotide residue wherein the oligonucleotide ranges in size from 10 to 1,000 nucleotides; n, and o are independently a positive integer; and provided that (o + n) e" 2, wherein L2 is a specified short moiety. Further provided is the use of the prodrugs for the preparation of a medicament to treat cancer.
Patent NZ-547120-A (NZ)
Title: Benzoxazine derivatives having 2,2-dialkyl substituents at the 2-position of the benzoxazine ring system
Inventor: BERGER JACOB
IPC: A61K31/538
Filed: 2004-11-30
Abstract: Disclosed are benzoxazine derivatives of formula (I) having 2,2-dialkyl substituents or other disubstitution (as defined in the specification) at the 2-position of the benzoxazine ring system that surprisingly results in greater affinity for 5-hydroxytryptamine receptors, particularly 5-HT-6, than is found in compounds wherein only hydrogen is present at the 2-position of the benzoxazine ring system, wherein the variables are as defined in the specification. These benzoxazine derivatives of formula (I) are suitable for treating a central nervous system disease state selected from psychoses, schizophrenia, manic depressions, neurological disorders, memory disorders, attention deficit disorder, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease, food uptake disorders, and Huntington's disease. These benzoxazine derivatives are also suitable for treating a disorder of the gastrointestinal tract.
Patent NZ-562255-A (NZ)
Title: Improved main tee connection
Inventor: LALONDE PAUL D
IPC: E04B9/00
Filed: 2006-04-20
Abstract: A grid runner is disclosed. The grid runner is of predetermined length, has a generally planar web and a separately formed clip attached to the web at each end. The web at each end of the runner has a portion deformed laterally out of the plane of the web. The web portion and the clip at each respective runner end form a pocket configured to receive a lead portion of an identical clip of a mating runner for connecting the runners together in a direct contact butt-type joint. The clips have inter-engaging projections and projection receiving areas each with a rearward facing locking surface. The clip is formed of a material substantially harder than the material forming the web. The web is notched forward of the pocket such that the web material forward of the locking surface of the clip and in the path of the locking projection of the identical clip to be connected is eliminated.
Patent NZ-564375-A (NZ)
Title: Inactivated chimeric flavivirus vaccines and related methods of use
Inventor: STERNER FRANK JAY
IPC: C12N15/40
Filed: 2006-06-23
Abstract: Disclosed is an inactivated chimeric flavivirus, comprising a first flavivirus in which the nucleotide sequences encoding the pre-membrane and envelope proteins are replaced with nucleotide sequences encoding pre-membrane and envelope proteins of a second flavivirus, wherein the first flavivirus is yellow fever virus and the second flavivirus is selected from West Nile virus, Japanese encephalitis virus, St Louis encephalitis virus, Dengue virus or a combination thereof.
Patent NZ-568886-A (NZ)
Title: Apparatus for removing sludge using a height adjustable suction head suspended from a float
Inventor: NEILSEN IAN BRADLEY
IPC: B01D21/18
Filed: 2006-11-22
Abstract: Apparatus (10) for removing solids such as sludge from a liquid reservoir is disclosed. The apparatus comprises a float (11), a suction head assembly (31) carrying a pump (37), and elongated guides (56) interconnecting the suction head assembly (31) and float (110). The float (1) also carries a winch for raising and lowering the suction head assembly (31). The guides (56) are slidably engaged with the float (11) and serve to indicate the depth of operation of the suction head assembly (31).
Patent NZ-569692-A (NZ)
Title: Wear assembly
Inventor: CARPENTER CHRISTOPHER M
IPC: E02F9/28
Filed: 2007-02-14
Abstract: A wear assembly for securing a wear member 12 to excavating equipment that includes a base having a nose and a wear member 12 having a front end to contact the materials of excavation and a socket 70 opening from the rear end. The socket of the wear member is defined by top, bottom and respective side walls and defines a longitudinal axis. At least one of the top and bottom walls includes a pair 112, 113 of centrally located stabilising surfaces that are inclined relative to each other in different transverse directions to laterally converge toward a central location 125 along the associated top or bottom wall. The stabilising surfaces bear against complementary surfaces on the nose to resist both vertical and horizontally applied loads during excavating action, and extend axially parallel to the longitudinal axis.
Patent NZ-578062-A (NZ)
Title: Ceramic particulate material and processes for forming same
Inventor: BAUER RALPH
IPC: C01F7/442
Filed: 2008-01-15
Abstract: Disclosed is a ceramic particulate material, comprising: alumina particles comprised of alpha phase alumina, the particles having an average primary particle size not greater than 135 nm as measured by TEM and/or a specific surface area (SSA) not less than 15 m2/g and not greater than 75 m2/g, and wherein the alumina particles have a sphericity quantified by at least one of (i) a mean roundness not less than 0.710 as measured by Roundness Correlation Image Analysis, and (ii) a concavity less than 20 percent, wherein concavity is the percent of alumina particles based on a sample of at least 100 particles, which have a concave outer peripheral portion that extends along a distance not less than 10 percent of d50 by TEM inspection, the concave outer peripheral portion having a negative radius of curvature as viewed from an interior of the particle. Methods for forming the ceramic particulate material are also disclosed.
Patent NZ-579754-A (NZ)
Title: Pyrimidinyl-piperazines useful as dopamine d3 /d2 receptor ligands
Inventor: BARTANE SZALAI GIZELLA
IPC: A61P25/00
Filed: 2008-04-10
Abstract: Disclosed herein is a 5,6-dichloropyrimidin-4-yl piperazine derivative of formula (I) wherein the substituents are as defined within the specification, processes for their preparation and pharmaceutical compositions comprising said derivative. Such compounds are useful in the treatment and/or prevention of conditions which require modulation of dopamine receptors such as psychoses, drug abuse, cognitive impairment accompanying schizophrenia, mild-to-moderate cognitive deficits, dementia, psychotic states associated with dementia, eating disorders, attention deficit disorders, hyperactivity disorders, psychotic depression, mania, bipolar disorder, paranoid and delusional disorders, dyskinetic disorders, depression and depressive states, anxiety disorders, sexual dysfunctions, sleep disorders, emesis, aggression, autism or pain.
Patent NZ-590954-A (NZ)
Title: Compounds as kinase inhibitors
Inventor: CHEN GUOQING PAUL
IPC: A01N43/42
Filed: 2009-08-13
Abstract: Disclosed are compounds of Formula (I), processes for their preparation, pharmaceutical compositions containing them as active ingredient, methods for the treatment of disease states associated with angiogenesis, such as cancers associated with protein tyrosine kinases, to their use as medicaments for use in the production of inhibition of tyrosine kinases reducing effects in warm-blooded animals such as humans. Examples of compounds of formula (I) are: 4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxy-7-[2-(5,8-Dioxa-10-azadispiro[2.0.4.3]-undecane)ethoxy]quinolone; 5-(2-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)ethyl)-5-azaspiro[2.4]-heptan-7-one; and 6-(6-Methoxy-7-(3-(7-methylene-5-azaspiro[2.4]heptan-5-yl)propoxy)quinolin-4-yloxy)-N-methyl-1-naphthamide
Patent NZ-593727-A (NZ)
Title: 5-(2-{ [6-(2,2-difluoro-2-phenylethoxy)hexyl]amino} -1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one for the treatment of lung function
Inventor: RUF THORSTEN
IPC: A61K31/4704
Filed: 2010-02-18
Abstract: 593727 Disclosed herein is the use of a compound which is 5-(2-{ [6-(2,2-difluoro-2-phenylethoxy) hexyl]amino} -1-hydroxyethyl)-8-hydroxyquinolin-2-(lH)-one in the form of a racemate, a stereoisomer or a mixture of stereoisomers, or a pharmaceutically acceptable salt or solvate thereof, in the manufacture of a medicament for use by inhalation in normalising the lung function of a human patient suffering from asthma, chronic obstructive pulmonary disease (COPD), muscular dystrophia, or gastro oesophageal reflux.